Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Grossman

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Digestive Diseases and Sciences|March 13, 2025
Correction to: Correlation Between Serum and Fecal Biomarkers and Patient‑Reported Outcomes in Patients with Crohn's Disease and Ulcerative ColitisKiran K Motwani, Madeline Alizadeh, Ameer Abutaleb, et al.
American Journal of Medical Genetics. Part A|July 1, 2021
Central 22q11.2 deletion (LCR22 B-D) in a fetus with severe fetal growth restriction and a mother with severe systemic lupus erythematosus: Further evidence of CRKL haploinsufficiency in the pathogenesis of 22q11.2 deletion syndromeIsabella Lin, Yalda Afshar, Jeffrey Goldstein, et al.
Digestive Diseases and Sciences|May 16, 2024
Correction to: Correlation Between Plasma and Fecal Biomarkers and Patient‑Reported Outcomes in Patients with Crohn's Disease and Ulcerative ColitisKiran K Motwani, Madeline Alizadeh, Ameer Abutaleb, et al.
Gastro Hep Advances|July 22, 2025
Insurance Denial of Biologic Therapy is Associated With Reduced Remission Rates in Inflammatory Bowel Disease PatientsErin Zisman, Madeline Alizadeh, Leah Rossmann, et al.
Lupus Science & Medicine|July 20, 2019
Comparison of PREDICTS atherosclerosis biomarker changes after initiation of new treatments in patients with SLEMaureen McMahon, Brian Skaggs, Jennifer Grossman, et al.
The Journal of Rheumatology|September 3, 2016
Treatments for Lupus Nephritis: A Systematic Review and Network MetaanalysisJasvinder A Singh, Alomgir Hossain, Ahmed Kotb, et al.
ACR Open Rheumatology|November 8, 2024
Anti-retinal Autoantibodies in Hydroxychloroquine Eye ToxicitySamuel D Good, Grazyna Adamus, Michael B Gorin, et al.
Ophthalmology. Glaucoma|March 31, 2022
The 24-2 Visual Field Guided Progression Analysis Can Miss the Progression of Glaucomatous Damage of the Macula Seen Using OCTDonald C Hood, Sol La Bruna, Emmanouil Tsamis, et al.
Blood Advances|April 9, 2024
Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndromeV Koneti Rao, Elaine Kulm, Jennifer Grossman, et al.
Arthritis and Rheumatism|May 1, 2007
Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteasesWei-Shiang Lin, Pei-Chih Chen, Cheng-De Yang, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Digestive Diseases and Sciences|March 13, 2025
Correction to: Correlation Between Serum and Fecal Biomarkers and Patient‑Reported Outcomes in Patients with Crohn's Disease and Ulcerative ColitisKiran K Motwani, Madeline Alizadeh, Ameer Abutaleb, et al.
American Journal of Medical Genetics. Part A|July 1, 2021
Central 22q11.2 deletion (LCR22 B-D) in a fetus with severe fetal growth restriction and a mother with severe systemic lupus erythematosus: Further evidence of CRKL haploinsufficiency in the pathogenesis of 22q11.2 deletion syndromeIsabella Lin, Yalda Afshar, Jeffrey Goldstein, et al.
Digestive Diseases and Sciences|May 16, 2024
Correction to: Correlation Between Plasma and Fecal Biomarkers and Patient‑Reported Outcomes in Patients with Crohn's Disease and Ulcerative ColitisKiran K Motwani, Madeline Alizadeh, Ameer Abutaleb, et al.
Gastro Hep Advances|July 22, 2025
Insurance Denial of Biologic Therapy is Associated With Reduced Remission Rates in Inflammatory Bowel Disease PatientsErin Zisman, Madeline Alizadeh, Leah Rossmann, et al.
Lupus Science & Medicine|July 20, 2019
Comparison of PREDICTS atherosclerosis biomarker changes after initiation of new treatments in patients with SLEMaureen McMahon, Brian Skaggs, Jennifer Grossman, et al.
The Journal of Rheumatology|September 3, 2016
Treatments for Lupus Nephritis: A Systematic Review and Network MetaanalysisJasvinder A Singh, Alomgir Hossain, Ahmed Kotb, et al.
ACR Open Rheumatology|November 8, 2024
Anti-retinal Autoantibodies in Hydroxychloroquine Eye ToxicitySamuel D Good, Grazyna Adamus, Michael B Gorin, et al.
Ophthalmology. Glaucoma|March 31, 2022
The 24-2 Visual Field Guided Progression Analysis Can Miss the Progression of Glaucomatous Damage of the Macula Seen Using OCTDonald C Hood, Sol La Bruna, Emmanouil Tsamis, et al.
Blood Advances|April 9, 2024
Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndromeV Koneti Rao, Elaine Kulm, Jennifer Grossman, et al.
Arthritis and Rheumatism|May 1, 2007
Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteasesWei-Shiang Lin, Pei-Chih Chen, Cheng-De Yang, et al.
Pageof 6